A Center of Excellence for Biomedical Research and Training in Africa
  
  

Student Title Journal Year PMID PMCID
Nyakutira C, Röshammar D, Chigutsa E, Chonzi P, Ashton M, Nhachi C, Masimirembwa C HIV Pharm High prevalence of the CYP2B6 516G–>T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe Eur J Clin Pharmacol 2007 18057928
Corbett EL, Makamure B, Cheung YB, Dauya E, Matambo R, Bandason T, Munyati SS, Mason PR, Butterworth AE, Hayes RJ HIV RCT HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe AIDS 2007 17301567
Bhunu CP, Garira W, Mukandavire Z, Zimba M TB Tx TB transmission model with chemopophylaxis and treatment Bull Math Biol 2008 18231839
Bhunu CP, Garira W, Mukandavire Z, Magombedze G. TB vac Modelling the effects of pre-exposure and post exposure vaccines in TB control J Theor Biol 2008 18644386
Gantt S, Carlsson J, Shetty AK, Seidel KD, Qin X, Mutsvangwa J, Musingwini G, Woelk G, Zijenah LS, Katzenstein DA, Frenkel LM. HIV Epi Cytomegalovirus and Epstein-Barr virus in breast milk are associated with HIV-1 shedding but not with mastitis AIDS 2008 18614868 PMC2504751
Monera TG, Wolfe AR, Maponga CC, Benet LZ, Guglielmo J OTH Pharm Moringa oleifera leaf extracts inhibit 6beta-hydroxylation of testosterone by CYP3A4 J Inf Devel Countries 2008 19745507
Bunhu CP, Garira W, Magombedze G HIV Pharm Mathematical analysis of a two strain HIV/AIDS model with antiretroviral treatment Acta Biother 2009 19357968
Mutsvangwa J, Millington KA, Chaka K, Mavhudzi T, Cheung YB, Mason PR, Butterworth AE, Corbett EL, Lalvani A TB Dx Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden Thorax 2009 20388756
Corbett EL, Bandason T, Cheung YB, Makamure B, Dauya E, Munyati SS, Churchyard GJ, Williams BG, Butterworth AE, Mungofa S, Hayes RJ, Mason PR TB Epi Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control Int J Tuberc Lung Dis 2009 19793427 PMC3374846
Thelingwani RS, Zvada SP, Dolgos H, Ungell AL, Masimirembwa CM OTH Pharm In vitro and in silico identification and characterization of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions Drug Metab Dispos 2009 19299526
Bhunu CP, Garira W, Mukandavire Z. HIV Epi Modeling HIV/AIDS and tuberculosis coinfection Bull Math Biol 2009 19475456
Zvada SP, Van Der Walt JS, Smith PJ, Fourie PB, Roscigno G, Mitchison D, Simonsson US, McIlleron HM TB Pharm Effects of four different meal types on the population pharmacokinetics of single-dose rifapentine in healthy male volunteers Antimicrob Ag Chemother 2010 20516273 PMC2916304
Gantt S, Carlsson J, Heath L, Bull ME, Shetty AK, Mutsvangwa J, Musingwini G, oelk G, Zijenah LS, Katzenstein DA, Mullins JI, Frenkel LM HIV Seq Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis J Virol 2010 20660189 PMC2950573
Dodd PJ, Millington KA, Ghani AC, Mutsvangwa J, Butterworth AE, Lalvani A, Corbett EL TB Dx Interpreting tuberculin skin tests in a population with a high prevalence of HIV, tuberculosis, and nonspecific tuberculin sensitivity Amer J Epidemiol 2010 20382638 PMC2858871
Gumbo FZ, Duri K, Kandawasvika GQ, Kurewa NE, Mapingure MP, Munjoma MW, Rusakaniko S, Chirenje MZ, Stray-Pedersen B HIV Epi Risk factors of HIV vertical transmission in a cohort of women under a PMTCT program at three peri-urban clinics in a resource-poor setting J Perinatol 2010 20336078 PMC2994594
Dimairo M, MacPherson P, Bandason T, Zezai A, Munyati SS, Butterworth AE, Mungofa S, Rusikaniko S, Fielding K, Mason PR, Corbett EL. TB Epi The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12 month cohort study in Harare, Zimbabwe PLoS One 2010 20676374 PMC2911383
Magombedze G, Nduru P, Bhunu CP, Mushayabasa S OTH qr Mathematical modelling of immune regulation of type 1 diabetes Biosystems 2010 20708063
Corbett EL, Zezai A, Cheung YB, Bandason T, Dauya E, Munyati SS, Butterworth AE, Rusikaniko S, Churchyard GJ, Mungofa S, Hayes RJ, Mason PR TB Dx Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status. Bull World Health Organ 2010 20428349 PMC2802433
Duri K, Gumbo FZ, Kristiansen KI, Kurewa NE, Mapingure MP, Rusakaniko S, Chirenje MZ, Muller F, Stray-Pedersen B HIV Tx Antenatal HIV-1 RNA load and timing of mother to child transmission; a nested case-control study in a resource poor setting Virol J 2010 20678190 PMC2919474
Corbett EL, Bandason T, Duong T, Dauya E, Makamure B, Churchyard GJ, Williams BG, Munyati SS, Butterworth AE, Mason PR, Mungofa S, Hayes RJ TB RCT Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial Lancet 2010 20923715 PMC2956882
Katsidzira L, Fana GT OTH Dx Pitfalls in the diagnosis of trypanosomiasis in low endemic countries: a case report PLoS Neg Trop Dis 2010 21200425 PMC3006137
Gumbo FZ, Kurewa NE, Kandawasvika GQ, Duri K, Mapingure MP, Munjoma MW, Pazvakavambwa IE, Rusakaniko S, Chirenje MZ, Stray-Pedersen B HIV Epi Rising mother-to-child HIV transmission in a resource-limited breastfeeding population Trop Doctor 2010 20305096
Masanganise R, Mukome A, Dari J, Makunike-Mutasa R HIV Clin Bilateral HIV related ocuar surface squamous neoplasia: a paradigm shift CAJM 2010 23457846
Midzi N, Mtapuri-Zinyowera S, Mapingure MP, Sangweme D, Chirehwa MT, Brouwer KC, Mudzori J, Hlerema G, Mutapi F, Kumar N, Mduluza T OTH Clin Consequences of polyparasitism on anaemia among primary school children in Zimbabwe Acat Trop 2010 20175980
Bhunu CP, Mushayabasa S, Tchuenche JM TB Tx A theoretical assessment of the effects of smoking on the transmission dynamics of TB Bull Math Biol 2011 20725798
Zvada SP, Denti P, Geldenhuys H, Meredith S, van As D, Hatherill M, Hanekom W, Wiesner L, Simonsson US, Jindani A, Harrison T, McIlleron HM TB Pharm Moxifloxacin population pharmacokinetics in patients with pulmonary tuberculosis and the effect of intermittent high-dose rifapentine Antimicrob Agents Chemother 2011 22585223 PMC3421597
Bhunu CP, Mushayabasa S OTH Tx Chancroid transmission dynamics: a mathematical modeling approach Theory Biosc 2011 21842439
Magwali TL, Mataya R, Munjanja SP, Chirehwa M OTH QR An assessment of the maternal death notification system in Zimbabwe–2006 CAJM 2011 24968656
Madzima TR, Boshoff M, Abuidris D, Tsikai N, Jones GW. OTH QR A successful clinical pilot registry of four radiation oncology practices in Africa and Ontario CAJM 2011 24968663
Katsidzira L, Fana GT, Makunike-Mutasa R, Ferrand RA HIV Clin Pneumomediastinum in an HIV-infected patient with cytomegalovirus pneumonitis Int J STD AIDS 2011 21464459
Chigutsa E, Visser ME, Swart EC, Denti P, Pushpakom S, Egan D, Holford NH, Smith PJ, Maartens G, Owen A, McIlleron H TB Pharm The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications Antimicrob Ag Chemother 2011 21709081 PMC3165308
Macpherson P, Dimairo M, Bandason T, Zezai A, Munyati SS, Butterworth AE, Mungofa S, Rusakaniko S, Fielding K, Mason PR, Corbett EL. TB Epi Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe Int J Tuberc Lung Dis 2011 22283900 PMC3272461
Tshabalala M, Manasa J, Zijenah LS, Rusakaniko S, Kadzirange G, Mucheche M, Kassaye S, Johnston E, Katzenstein D. HIV Pharm Surveillance of transmitted antiretroviral drug resistance among HIV-1 infected women attending antenatal clinics in Chitungwiza, Zimbabwe PLoS One 2011 21698125 PMC3116901
Bepe N, Madanhi N, Mudzviti T, Gavi S, Maponga CC, Morse GD HIV Pharm The impact of herbal remedies on adverse effects and quality of life in HIV-infected individuals on antiretroviral therapy J Inf Devel Countries 2011 21330740 PMC3424263
Duri K, Müller F, Gumbo FZ, Kurewa NE, Rusakaniko S, Chirenje MZ, Mapingure MP, Stray-Pedersen B HIV Tx Human Immunodeficiency Virus (HIV) types Western blot (WB) band profiles as potential surrogate markers of HIV disease progression and predictors of vertical transmission in a cohort of infected but antiretroviral therapy naïve pregnant women in Harare, Zimbabwe BMC Inf Dis 2011 21211021 PMC3022718
Mushayabasa S, Tchuenche JM, Bhunu CP, Ngarakana-Gwasira E HIV Mod Modeling gonorrhea and HIV co-infection Biosystems 2011 20869424
Mushayabasa S, Bhunu CP HIV Mod Modeling schistosomiasis and HIV/AIDS codynamics. Comp Math Methods Med 2011 20869424
Tchuenche JM, Dube N, Bhunu CP, Smith RJ, Bauch CT OTH Tx The impact of media coverage on transmission dynamics of human influenza BMC Pub Hlth 2011 21356134 PMC3317585
Fana GT, Ndhlovu CE HIV Clin Renal dysfunction among anti-retroviral therapy naïve HIV infected patients in Zimbabwe CAJM 2011 24968654
Midzi N, Mtapuri-Zinyowera S, Mapingure MP, Paul NH, Sangweme D, Hlerema G, Mutsaka MJ, Tongogara F, Makware G, Chadukura V, Brouwer KC, Mutapi F, Kumar N, Mduluza T OTH Epi Knowledge attitudes and practices of grade three primary schoolchildren in relation to schistosomiasis, soil transmitted helminthiasis and malaria in Zimbabwe BMC Inf Dis 2011 21668948 PMC3141409
Midzi N, Mtapuri-Zinyowera S, Sangweme D, Paul NH, Makware G, Mapingure MP Brouwer KC, Mudzori J, Hlerema G, Chadukura V, Mutapi F, Kumar N, Mduluza T OTH RCT Efficacy of integrated school based de-worming and prompt malaria treatment on helminths -Plasmodium falciparum co-infections: A 33 months follow up study. BMC Int Hlth Hum Rights 2011 21696629 PMC3141662
Duri K, Soko W, Gumbo F, Kristiansen K, Mapingure M, Stray-Pedersen B, Muller F HIV Seq Genotypic analysis of human immunodeficiency virus type 1 env V3 loop sequences: bioinformatics prediction of coreceptor usage among 28 infected mother-infant pairs in a drug-naive population AIDS Res Human Retrovir 2011 20969460
Gumbo FZ, Kandawasvika GQ, Duri K, Mapingure MP, Kurewa NE, Nathoo K, Rusakaniko S, Chirenje MZ, Stray-Pedersen B HIV Tx Reduced HIV transmission at subsequent pregnancy in a resource-poor setting Trop Doctor 2011 21576348 PMC3128383
Duri K, Gumbo F, Kristiansen K, Mapingure M, Munjoma M, Chirenje M, Rusakaniko S, Stray-Pedersen B, Műller F. HIV Seq Phylogenetic analysis of human immunodeficiency virus type 1 subtype C env gp120 sequences among four drug-naive families following subsequent heterosexual and vertical transmissions AIDS Res Human Retrovir 2012 22206228
Dahlman KB, Parker JS, Shamu T, Hieronymus H, Chapinski C, Carver B, Chang K, Hannon GJ, Sawyers CL OTH Dx Modulators of prostate cancer cell proliferation and viability identified by short-hairpin RNA library screening PLoS One 2012 22509301 PMC3324507
Dzangare J, Gonese E, Mugurungi O, Shamu T, Apollo T, Bennett DE, Kelley KF, Jordan MR, Chakanyuka C, Cham F, Banda RM HIV Pharm Monitoring of early warning indicators for HIV drug resistance in antiretroviral therapy clinics in Zimbabwe Clin Inf Dis 2012 22544194 PMC3338304
Mushayabasa S, Bhunu CP HIV Mod Is HIV infection associated with an increased risk for cholera? Insights from a mathematical model Biosystems 2012 22609496
Mureyi DD, Monera TG, Maponga CC OTH Pharm Prevalence and patterns of prenatal use of traditional medicine among women at selected harare clinics: a cross-sectional study BMC Complement Altern Med 2012 23016608 PMC3533916
Mudzviti T, Maponga CC, Khoza S, Ma Q, Morse GD HIV Pharm The impact of herbal drug use on adverse drug reaction profiles of patients on antiretroviral therapy in Zimbabwe AIDS Res Treat 2012 22506106 PMC3313558
Ricks PM, Mavhunga F, Modi S, Indongo R, Zezai A, Lambert LA, DeLuca N, Krashin JS, Nakashima AK, Holtz TH. TB Pharm Characteristics of multidrug-resistant tuberculosis in Namibia BMC Inf Dis 2012 23273024 PMC3547706
Chigutsa E, Meredith S, Wiesner L, Padayatchi N, Harding J, Moodley P, MacKenzie WR, Weiner M, McIlleron H, Kirkpatrick CM TB Pharm Population pharmacokinetics and pharmacodynamics of ofloxacin in South African patients with multidrug-resistant TB Antimicrob Ag Chemother 2012 22564839 PMC3393408
Musarurwa C, Nyamayaro T, Mujaji WB, Matarira HT, Gomo ZA OTH QR Clinical laboratory test prices in Zimbabwe: A case of profiteering? CAJM 2012 26255327
Gwanzura L, Mayini J, Mabhanga K, Chipinduro J, Mashamba K, Mutenherwa M, Mutambu SL, Mutsvangwa J, Mason PR OTH Dx Evaluation of “Cyscope”, a novel fluorescence-based microscopy technique for the detection of malaria. J Inf Dis Devel Countries 2012 22337855
Malunga G, Mujaji WB, Musarurwa C, Nyamayaro T HIV Pharm Investigation of the effect of Stalanev (Stavudine, Lamivudine and Nevirapine) treatment on plasma lactate levels in adults attending Beatrice Road and Wilkins Infectious Diseases Hospital Opportunistic Infections Clinics in Harare, Zimbabwe CAJM 2012 26255331
Mudzviti T, Sibanda M, Gavi S, Maponga CC, Morse GD HIV Pharm Implementing a pharmacovigilance program to evaluate cutaneous adverse drug reactions in an antiretroviral access program J Inf Dis Devel Countries 2012 23277506 PMC3313558
Bhunu CP, Mushayabasa S HIV Pharm Assessing the effects of drug misuse on HIV/AIDS prevalence Theory Biosc 2013 23225069
Chigutsa E, Patel K, Denti P, Visser M, Maartens G, Kirkpatrick CM, McIlleron H, Karlsson MO TB Pharm A time-to-event pharmacodynamic model describing treatment response in patients with pulmonary tuberculosis using days to positivity in automated liquid mycobacterial culture Antimicrob Ag Chemother 2013 23183433 PMC3553722
Eaton JW, Garnett GP, Takavarasha FR, Mason PR, Robertson L, Schumacher CM, Nyamukapa CA, Gregson S HIV Epi Increasing adolescent HIV prevalence in Eastern Zimbabwe–evidence of long-term survivors of mother-to-child transmission? PLoS One 2013 23950938 PMC3737189
Makamure B, Mhaka J, Makumbirofa S, Mutetwa R, Mupfumi L, Mason P, Metcalfe JZ TB Dx Microscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, Zimbabwe PLoS One 2013 23409072 PMC3569460
Mushayabasa S, Bhunu CP TB Pharm Modeling the impact of early therapy for latent TB patients and its optimal control analysis j Bio Phys 2013 23975671 PMC3758829
Pillai G, Davies G, Denti P, Steimer JL, McIlleron H, Zvada S, Chigutsa E, Ngaimisi E, Mirza F, Tadmor B, Holford NH OTH Pharm Pharmacometrics: opportunity for reducing disease burden in the developing world: the case of Africa CPT Phar Syst Pharmacol 2013 23985967 PMC3828009
Zvada SP, Denti P, Sirgel FA, Chigutsa E, Hatherill M, Charalambous S, Mungofa S, Wiesner L, Simonsson US, Jindani A, Harrison T, McIlleron HM TB Pharm Moxifloxacin population pharmacokinetics and model-based comparison of efficacy between moxifloxacin and ofloxacin in African patients Antimicrob Ag Chemother 2013 24189253 PMC3910772
Mudzinge D, Nyazika TK, Chisango TJ, Zhou DT HIV Clin Differences in serum Levels of Magnesium, Phosphate, and Albumin for HAART-experienced and HAART-naïve female patients attending Parirenyatwa Opportunistic Infections Clinic in Harare, Zimbabwe ISRN AIDS 2013 24093073 PMC3777213
Dondo V, Mujuru HA, Nathoo KJ, Chirehwa M, Mufandaedza Z HIV Clin Renal abnormalities among HIV-infected, antiretroviral naive children, Harare, Zimbabwe: a cross-sectional study BMC Pediatr 2013 23663553 PMC3654941
Chawana TD, Reid A, Bwakura T, Gavi S, Nhachi CF, HIV Pharm Factors influencing treatment failure in HIV positive adult patients on first line antiretroviral therapy CAJM 2014 26867253
Mhandire K, Duri K, Kandawasvika G, Chandiwana P, Chin’ombe N, Kanyera RB, Stray-Pedersen B, Dandara C HIV Seq CCR2, CX3CR1, RANTES and SDF1 genetic polymorphisms influence HIV infection in a Zimbabwean pediatric population J Inf Dev Countries 2014 25313609
Eaton JW, Takavarasha FR, Schumacher CM, Mugurungi O, Garnett GP, Nyamukapa C, Gregson S HIV Epi Trends in concurrency, polygyny, and multiple sex partnerships during a decade of declining HIV prevalence in eastern Zimbabwe J Infect Dis 2014 23950938 PMC4231639
Mupfumi L, Makamure B, Chirehwa M, Sagonda T, Zinyowera S, Mason P, Metcalfe JZ, Mutetwa R TB Dx Impact of Xpert MTB/RIF on antiretroviral therapy-associated tuberculosis and mortality: A pragmatic randomized controlled trial Open Forum Inf Dis 2014 25734106 PMC4324195
Mhandire K, Pharo G, Kandawasvika GQ, Duri K, Swart M, Stray-Pedersen B, Dandara C HIV Seq How does mother-to-child transmission of HIV differ among African populations? Lessons from MBL2 genetic variation in Zimbabweans OMICS 2014 24601758 PMC4086031
Skelton MM, Kampira EE, Wonkam AA, Mhandire KK, Kumwenda JJ, Duri KK, Dandara CC HIV Seq Frequency variation among sub-Saharan populations in virus restriction gene BST-2 proximal promoter polymorphisms: implications for HIV-1 prevalence differences among African countries OMICS 2014 24601767
Murahwa AT, Muchemwa FC, Duri K, Borok MZ, Kanyera RB, Manhanzva MT, Mapingure, MP, Stray-Pedersen B OTH Dx Presence of Betapapillomavirus in Kaposi sarcoma lesions J Med Virol 2014 24706580
Ondoa P, Shamu T, Bronze M, Wellington M, Boender TS, Manting C, Steegen K, Luethy R, Rinke de Wit T HIV Dx Performance and logistical challenges of alternative HIV-1 virological monitoring options in a clinical setting of Harare, Zimbabwe Biomed Res Int 2014 25025031 PMC4082876
Chitsike I, Ndlovu N, Kuona P, Nyakabau AM, Kadzatsa W, Ticklay I, Chimhini G, Chokonunga E OTH QR Childhood Cancers in Zimbabwe: A 10 year review of the Zimbabwe National Cancer Registry data CAJM 2014 26867248
Mutsvangwa J, Beck IA, Gwanzura L, Manhanzva MT, Stranix-Chibanda L, Chipato T, Frenkel LM HIV Dx Optimization of the oligonucleotide ligation assay for the detection of nevirapine resistance mutations in Zimbabwean Human Immunodeficiency Virus type-1 subtype C J Virol Methods 2014 25239368 PMC4363305
Smith J, Nyamukapa C, Gregson S, Lewis J, Magutshwa S, Schumacher C, Mushati P, Hallett T, Garnett G. HIV Epi The distribution of sex acts and condom use within partnerships in a rural sub-Saharan African population PLoS One 2014 24558387 PMC3928170
Sagonda T, Mupfumi L, Manzou R, Makamure B, Tshabalala M, Gwanzura L, Mason P, Mutetwa R. TB Epi Prevalence of Extensively Drug Resistant tuberculosis among archived Multidrug Resistant Tuberculosis isolates in Zimbabwe Tuberc Res Treat 2014 24967101 PMC4054961
Kuona P, Mashavave G, Kandawasvika GQ, Mapingure MP, Masanganise M Chandiwanda P, Munjoma M, Nathog KJ, Stray-Pedersen B OTH Epi Anaemia and iron deficiency in peri-urban school children born in a National HIV Prevention Programme in Zimbabwe: A cross-sectional study CAJM 2014 26867252
Jeremiah K, Denti P, Chigutsa E, Faurholt-Jepsen D, PrayGod G, Range N, CastelS, Wiesner L, Hagen CM, Christiansen M, Changalucha J, McIlleron H, Friis H,Andersen AB TB Pharm Nutritional supplementation increases rifampin exposure among tuberculosis patients coinfected with HIV Antimicrob Ag Chemother 2014 24709267 PMC4068463
Gray J, Fana GT, Campbell TB, Hakim JG, Borok MZ, Aagaard EM OTH QR Feasibility and sustainability of an interactive team-based learning method for medical education during a severe faculty shortage in Zimbabwe BMC Med Ed 2014 24678606 PMC3972960
Gumbo T, Chigutsa E, Pasipanodya J, Visser M, van Helden PD, Sirgel FA, McIlleron H TB Pharm The pyrazinamide susceptibility breakpoint above which combination therapy fails J Antimicrob Chemother 2014 24821594 PMC4130380
Lessells RJ, Stott KE, Manasa J, Naidu KK, Skingsley A, Rossouw T, de Oliveira HIV Pharm Southern African Treatment and Resistance Network (SATuRN). Implementing antiretroviral resistance testing in a primary health care HIV treatment programme in rural KwaZulu-Natal, South Africa: early experiences, achievements and challenges BMC Hlth Serv Res 2014 24606875 PMC3973961
Manasa J, Danaviah S, Pillay S, Padayachee P, Mthiyane H, Mkhize C, Lessells RJ, Seebregts C, de Wit TF, Viljoen J, Katzenstein D, De Oliveira T. HIV Pharm An affordable HIV-1 drug resistance monitoring method for resource limited settings. J Vis Exp 2014 24747156 PMC4024245
Metcalfe JZ, Makumbirofa S, Makamure B, Sandy C, Bara W, Mungofa S, Hopewell PC, Mason P TB Pharm Drug-resistant tuberculosis in high-risk groups, Zimbabwe Emerg Inf Dis 2014 24377879 PMC3884722
Takuva S, Mugurungi O, Mutsvangwa J, Machiha A, Mupambo AC, Maseko V, Cham F, Mungofa S, Mason P, Lewis DA OTH Epi Etiology and antimicrobial susceptibility of pathogens responsible for urethral discharge among men in Harare, Zimbabwe Sex Trans Dis 2014 25581806
Kaseke F, Mutsambi M Experiences of health science students during clinical placements at theUniversity of Zimbabwe CAJM 2014 26867255
Chigutsa E, Pasipanodya JG, Visser ME, van Helden PD, Smith PJ, Sirgel FA, Gumbo T, McIlleron H TB Pharm Impact of nonlinear interactions of pharmacokinetics and MICs on sputum bacillary kill rates as a marker of sterilizing effect in TB Antimicrob Ag Chemother 2015 25313213 PMC4291375
Zvada SP, Denti P, Donald PR, Schaaf HS, Thee S, Seddon JA, Seifart HI, Smith PJ, McIlleron HM, Simonsson US. TB Pharm Population pharmacokinetics of rifampicin, pyrazinamide and isoniazid in children with tuberculosis: in silico evaluation of currently recommended doses J Antimicrob Chemother 2014 24486870 PMC3977610
Jindani A, Harrison TS, Nunn AJ, Phillips PP, Churchyard GJ, Charalambous S, Hatherill M, Geldenhuys H, McIlleron HM, Zvada SP, Mungofa S, Shah NA, Zizhou S, Magweta L, Shepherd J, Nyirenda S, van Dijk JH, Clouting HE, Coleman D, Bateson AL, McHugh TD, Butcher PD, Mitchison DA; RIFAQUIN Trial Team. TB Pharm High-dose rifapentine with moxifloxacin for pulmonary tuberculosis N Engl J Med 2014 25337749 PMC4233406
Dambi JM, Makotore FG, Kaseke F The Impact of Caregiving a Child with Cancer: A Cross Sectional Study of Experiences of Zimbabwean Caregivers J Palliat Care Med 2015
Makadzange AT, Higgins-Biddle M, Chimukangara B, Birri R, Gordon M, Mahlanza T, McHugh G, van Dijk JH, Bwakura-Dangarembizi M, Ndung’u T, Masimirembwa C, Phelps B, Amzel A, Ojikutu BO, Walker BD, Ndhlovu CE HIV Clinical, virologic, immunologic outcomes and emerging drug resistance in adolescents in public ART care in Zimbabwe PLoS One 2015 26658814 PMC4678607
Denti P, Jeremiah K, Chigutsa E, Faurholt-Jepsen D, PrayGod G, Range N, Castel S, Wiesner L, Hagen CM, Christiansen M, Changalucha J, McIlleron H, Friis H, Andersen AB TB Pharm Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Newly Diagnosed Pulmonary TB Patients in Tanzania PLoS One 2015 26501782 PMC4621059
Chirehwa MT, Rustomjee R, Mthiyane T, Onyebujoh P, Smith P, McIlleron H, Denti TB Pharm Model-based evaluation of higher doses of Rifampin using a semimechanistic model incorporating autoinduction and saturation of hepatic extraction Antimicrob Ag Chemother 2015 26552972 PMC4704145
Metcalfe JZ, Makumbirofa S, Makamure B, Mutetwa R, Peñaloza RA, Sandy C, Bara W, Mungofa S, Hopewell PC, Mason P TB Dx Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients Eur Respir J 2015 25792637
M’kumbuzi NS, Kaseke F Use of non-steroidal anti-inflammatory drugs and nutritional supplements in Zimbabwean football. S Afr J Sports Med 2015
Hofmeyr GJ, Seuc AH, Betrán AP, Purnat TD, Ciganda A, Munjanja SP, Manyame S, Singata M, Fawcus S, Frank K, Hall DR, Cormick G, Roberts JM, Bergel EF, Drebit SK, Von Dadelszen P, Belizan JM OTH Pharm The effect of calcium supplementation on blood pressure in non-pregnant women with previous pre-eclampsia: An exploratory, randomized placebo controlled study Pregnancy Hypertens 2015 26597740
Sande S, Zimba M, Chinwada P, Masendu H, Mazando S, Makuwaza A OTH Epi The emergence of insecticide resistance in the major malaria vector Anopheles funestus (Diptera: Culicidae) from sentinel sites in Mutare and Mutasa Districts Zimbabwe Malaria J 2015 26589891 PMC4654866
Esber A, Moyo P, Munjoma M, Francis S, van de Wijgert J, Chipato T, Turner AN. HIV Tx Cessation of intravaginal practices to prevent bacterial vaginosis: a pilot intervention in Zimbabwean women Sex Trans Inf 2015 25355772
Murahwa AT, Muchemwa FC, Duri K, Kanyera RB, Tshabalala M, Manhanzva MT Mapingure MP, Stray-Pedersen B HIV Epi Frequency of Betapapillomavirus infections among HIV infected and uninfected Black Zimbabweans with cutaneous lesions J Med Virol 2015 25359659
Bwakura-Dangarembizi M, Musiime V, Szubert AJ, Prendergast AJ, Gomo ZA, Thomason MJ, Musarurwa C, Mugyenyi P, Nahirya P, Kekitiinwa A, Gibb DM, Walker AS, Nathoo K; ARROW Trial Team HIV Epi Prevalence of lipodystrophy and metabolic abnormalities in HIV-infected African children after 3 years on first-line antiretroviral therapy Pediatr Infect Dis J 2015 25068287 PMC4369579
Boender TS, Hoenderboom BM, Sigaloff KC, Hamers RL, Wellington M, Shamu T, Siwale M, Labib Maksimos EE, Nankya I, Kityo CM, Adeyemo TA, Akanmu AS, Mandaliya K, Botes ME, Ondoa P, Rinke de Wit TF HIV Pharm Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa Clin Infect Dis 2015 26240203
Tshabalala M, Mellet J, Pepper MS. OTH QR Human Leukocyte Antigen Diversity: A Southern African Perspective J Immunol Res 2015 26347896 PMC4549606
Mhandire D, Lacerda M, Castel S, Mhandire K, Zhou D, Swart M, Shamu T, Smith P, Musingwini T, Wiesner L, Stray-Pedersen B, Dandara C. HIV Seq Effects of CYP2B6 and CYP1A2 genetic variation on Nevirapine plasma concentration and pharmacodynamics as measured by CD4 Cell Count in Zimbabwean HIV-infected patients OMICS 2015 26348712 PMC4575538
Dhoro M, Zvada S, Ngara B, Nhachi C, Kadzirange G, Chonzi P, Masimirembwa C HIV Seq CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe BMC Pharmacol Toxicol. 2015 25889207 PMC4405819
Shamu T, Wellington M, Pascoe M, Gwanzura L, Ndhlovu CE. Incidence of nephropathy in HIV infected patients receiving HAART at Newlands Clinic, Harare World J AIDS 2015
Manasa J, Katzenstein D HIV Pharm Editorial Commentary: Scaling up antiretroviral therapy in Africa: Are we there yet? Clin Inf Dis 2016 26561533
Nyazika TK, Robertson VJ, Nherera B, Mapondera PT, Meis JF, Hagen F. OTH Dx Comparison of biotyping methods as alternative identification tools to molecular typing of pathogenic Cryptococcus species in sub-Saharan Africa Mycoses 2016 26661484 PMC4761295
Laboratory Services Offered




ISO 15189 Certified


Online Resources